| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f06161c8222218d91d43831cf9cc228 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09747b5490c6081de0c85e2570b28e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac1c1f8f0e7eecd57b4743c4c62057a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee0db7eb8518eed8d25670893e0c7e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7659508e5b6d65c4045cef61525ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d139179aa4744145c98963801e3a67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f64e0a39a3e3188c823505c5be8203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f7bc05a181d55016a68f828bed030d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1827c527bdafacbf27a6c2f38535642f |
| publicationDate |
2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220051246-A |
| titleOfInvention |
Treatment of diabetic retinopathy with fully human post-translational modified anti-VEGF Fab |
| abstract |
Fully human post-translational modified (HuPTM) monoclonal antibody ("mAb") or antigen binding fragment of a mAb to human vascular endothelial growth factor ("hVEGF") - such as fully human-glycosylated (HuGly) anti-hVEGF antigen binding Compositions and methods are described for delivering fragment-to the retina/vitreous humor of the eye(s) of a human subject diagnosed with diabetic retinopathy. |
| priorityDate |
2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |